Hamburg/Sharfstein Choice Underscores Public Health, Stricter Oversight
This article was originally published in The Rose Sheet
Executive Summary
The White House's appointment of two former health commissioners to run FDA sends a strong message that the agency is refocusing on public health
You may also be interested in...
Taylor Is Sharfstein's Temporary Replacement As FDA's Second-In-Command
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Joshua Sharfstein's departure.
Taylor Is Sharfstein's Temporary Replacement As FDA's Second-In-Command
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Joshua Sharfstein's departure.
Newcomers To White House, FDA Augur Up-Regulation: Top Stories Of 2009
The prospect of heightened regulation under the Obama administration and a reorganized FDA - in an environment characterized by high pressure from public safety groups - commanded the attention of personal-care interests in 2009